BridgeMD
New treatment option for Problem Behavior
Official title Evaluation of the Invest in Play Program - a New Parent Intervention for Children With Problem Behavior
ClinicalTrials.gov ID: NCT06984809
What this study is testing
- What it's testing
- The goal of this clinical trial is to test if the invest in Play (iiP) parent program can reduce problem behaviors in children and improve parenting practices in families with children who show challenging behaviors. The main questions it aims to answer is: Does the iiP program reduce children's problem behaviors?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Parents of children between 6-12 years of age referred to out-patient clinics for treatment of behavioural problems.
- Children scoring above a pre-defined mean cut off score (over the 90 percentile) on the Eyberg Child Behavior Inventory (ECBI; Eyberg \& Ross, 1978)...
You likely can't join if
- \- Severe developmental delay (in children or parents), autism spectrum disorder, inability to understand Norwegian, or other reasons why the...
The study team makes the final eligibility decision.
Where it's taking place
- Bergen, Fyllingdalen, Norway
- Bergen, Norway
- Haugesund, Norway
- Namsos, Norway
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bergen, Fyllingdalen, Norway; Bergen, Norway; Haugesund, Norway; Namsos, Norway; Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.